RESUMO
Abstract The aim of this study was to evaluate tumor necrosis factor alpha (TNF-α), interleukin (IL)- 17A/F levels in the serum of ankylosing spondylitis (AS) patients after anti-TNF therapy, in order to understand how these cytokines are involved in this therapeutic response. Forty-four AS patients were included in the study: thirty using anti-TNF therapy were classified according to their therapy response as responders (15) and non-responders (15) and 14 without anti-TNF therapy were classified as AS control. Fifteen healthy individuals formed the control group. Serum levels of TNF-α were determined using Luminex technology and for IL-17A and IL-17F using ELISA. The non-responder patients presented higher serum levels of TNF-α than the responders and AS control; the same results were found when HLA-B*27 positive or negative patients were separately analyzed. IL-17A and IL17F serum levels were similar for all groups. According to the clinical disease activity, AS patients with BASDAI ≥4 had higher serum levels of TNF-α than AS patients with BASDAI <4. Positive correlation was found between TNF-α levels and BASDAI. In AS patients, TNF-α serum levels were associated with anti-TNF therapy and disease activity independently of HLA-B*27, and IL-17A and IL-17F were not related to anti-TNF treatment
Assuntos
Humanos , Masculino , Feminino , Pacientes/classificação , Espondilite Anquilosante/patologia , Fator de Necrose Tumoral alfa/análise , Interleucina-17/análise , Polimorfismo Genético , Citocinas/classificação , Estudos de Associação Genética/instrumentaçãoRESUMO
Abstract Bleaching gel containing hydrogen peroxide (H2O2) cause damages in pulp tissue. This study investigated the action of a topical anti-inflammatory, the Otosporin®, in rats' bleached teeth with the null hypothesis of which the Otosporin® is no able to minimize the pulp inflammation that bleaching gel generates. The rat's molars were divided into groups: BLE: bleached (35% H2O2 concentration /single application of 30 min); BLE-O: bleached followed by Otosporin® (10 min); and control: placebo gel. In the second day after dental bleaching, the rats were killed, and the jaws were processed for hematoxylin-eosin and immunohistochemistry analysis for tumor necrosis factor alpha (TNF-α), interleukin (IL)-6 and IL-17. The data collected were subjected to Kruskal-Wallis and Dunn statistical tests with at a 5% level of significance (p<0.05). The BLE group had moderate to strong inflammation in the occlusal third of the coronary pulp, with necrotic areas; and BLE-O, mild inflammation (p<0.05). There was a significant difference in the occlusal and middle thirds of the coronary pulp between the BLE with BLE-O and control groups (p<0.05). There was no difference in the cervical third (p>0.05). The BLE group had a high immunoexpression of TNF-α than BLE-O and control groups (p<0.05), with moderate and mild immunoexpression, respectively. Regarding IL-6 and IL-17, the BLE group had higher immunoexpression than control (p<0.05); the BLE-O was similar to the control (p>0.05). The topical anti-inflammatory Otosporin® can reduce pulp inflammation after dental bleaching in the rat teeth.
Resumo O gel clareador à base de peróxido de hidrogênio (H2O2) causa danos ao tecido pulpar. Este estudo investigou a ação de um anti-inflamatório tópico, o Otosporin®, nos dentes de ratos clareados com a hipótese nula de que o Otosporin® não é capaz de minimizar a inflamação da polpa gerada pelo gel clareador. Os molares dos ratos foram divididos em grupos: ClA: clareado (H2O2 a 35% / aplicação única de 30 min); CLA-O: clareado seguido do Otosporin® (10 min); e controle: gel placebo. No segundo dia após a clareação dentária, os ratos foram mortos e suas maxilas foram processadas para análise de hematoxilina-eosina e imunohistoquímica para o fator de necrose tumoral alfa (TNF-a), interleucina (IL)-6 e IL-17. Os dados coletados foram submetidos aos testes estatísticos de Kruskal-Wallis e Dunn com um nível de significância de 5% (p<0,05). O grupo CLA apresentou inflamação moderada à severa no terço oclusal da polpa coronária, com áreas necróticas; e CLA-O, inflamação leve (p<0,05). Houve diferença significativa nos terços oclusal e médio da polpa coronária entre o grupo CLA com os grupos CLA-O e controle (p<0,05). Não houve diferença no terço cervical (p>0,05). O grupo CLA apresentou maior imunoexpressão para TNF-a comparado aos grupos CLA-O e controle (p<0,05), com imunoexpressão moderada e leve, respectivamente. Em relação a IL-6 e IL-17, o grupo CLA apresentou maior imunoexpressão comparado ao controle (p<0,05); o CLA-O foi semelhante ao controle (p>0,05). O anti-inflamatório tópico Otosporin® pode reduzir a inflamação pulpar após clareação em dentes de ratos.
Assuntos
Animais , Ratos , Polimixina B/farmacologia , Pulpite/induzido quimicamente , Pulpite/prevenção & controle , Clareamento Dental/efeitos adversos , Hidrocortisona/farmacologia , Neomicina/farmacologia , Hidrocortisona/administração & dosagem , Imuno-Histoquímica , Biomarcadores/análise , Administração Tópica , Interleucina-6/análise , Fator de Necrose Tumoral alfa/análise , Interleucina-17/análise , Combinação de Medicamentos , Peróxido de Hidrogênio/efeitos adversosRESUMO
ABSTRACT Introduction: The search for more aesthetic and comfortable orthodontic devices has led to an increase in the use of clear aligners. Objective: To increase knowledge on biological mechanisms of orthodontic tooth movement using Invisalign aligners. Methods: This study included 11 patients with a mean age of 23.6 ± 4.8 years. Cases planning included alignment and leveling of lower incisors using Invisalign aligners. Gingival crevicular fluid samples were collected from the lower incisors on the day of delivery of aligner number 1 (T0) and after 1 (T24h), 7 (T7d), and 21 (T21d) days. During the observation period of the study, the patients used only the aligner number 1. Levels of nine cytokines were quantified using Luminex's multi-analysis technology. Non-parametric tests were used for comparisons between cytokine expression levels over time. Results: Cytokine expression levels remained constant after 21 days of orthodontic activation, except those of MIP-1β, which presented a statistical difference between T24h and T21d with a decrease in the concentration levels. IL-8, GM-CSF, IL-1β, MIP-1β, and TNF-α showed the highest concentrations over time. Conclusions: The different behavior in the levels of the investigated cytokines indicates a role of these biomarkers in the tissue remodeling induced by Invisalign.
RESUMO Introdução: a busca por dispositivos ortodônticos mais estéticos e confortáveis gerou um aumento no uso de alinhadores transparentes. Objetivo: ampliar o conhecimento sobre os mecanismos biológicos associados ao movimento dentário ortodôntico promovido por alinhadores Invisalign®. Métodos: a amostra foi constituída por 11 pacientes, com idade média de 23,6 ± 4,8 anos. O planejamento dos casos incluiu alinhamento e nivelamento de incisivos inferiores usando os alinhadores. O fluido gengival crevicular foi coletado na superfície vestibular de incisivos inferiores no dia da entrega do alinhador número 1 (T0) e após 1 (T24h), 7 (T7d) e 21 (T21d) dias. Durante o período de observação do estudo, os pacientes utilizaram apenas o alinhador número 1. Os níveis de nove citocinas foram quantificados por meio do sistema Luminex de multianálise. Testes não paramétricos foram realizados para comparações entre os níveis de expressão de citocinas ao longo do tempo. Resultados: a concentração das citocinas manteve-se constante após 21 dias de ativação ortodôntica, exceto a MIP-1β, que apresentou uma redução estatisticamente significativa entre os tempos T24h e T21d. As IL-8, GM-CSF, IL-1β, MIP-1β e TNF-α apresentaram as maiores concentrações ao longo do tempo. Conclusão: a constância na expressão dos níveis das citocinas parece estar compatível com o estímulo mecânico induzido por alinhadores.
Assuntos
Humanos , Masculino , Feminino , Adulto Jovem , Técnicas de Movimentação Dentária , Citocinas/análise , Líquido do Sulco Gengival/química , Aparelhos Ortodônticos Removíveis , Citocinas/metabolismo , Fator Estimulador de Colônias de Granulócitos e Macrófagos/análise , Interleucina-8/análise , Fatores Estimuladores de Colônias/análise , Interleucina-7/análise , Fator de Necrose Tumoral alfa/análise , Quimiocina CCL2/análise , Interleucina-17/análise , Interleucina-1beta/análise , Quimiocina CCL4/análise , IncisivoRESUMO
Immunological mechanisms have been proposed to underlie the pathogenesis of recurrent spontaneous abortion (RSA). Vitamin D has a potent immunomodulatory effect, which may affect pregnancy outcome. The objective of this study was to investigate 25-hydroxyvitamin D [25(OH) D] concentration and vitamin D receptor (VDR) expression in the decidual tissues of RSA patients. Thirty women with RSA (RSA group) and thirty women undergoing elective abortion (control group) were recruited during 2016 from gynecology outpatient clinics. We measured 25(OH) D, interleukin (IL)-17, IL-23, transforming growth factor β (TGF-β), VDR and 1-α-hydroxylase (CYP27B1) in decidual tissues collected during the abortion procedure. In the RSA group, 25(OH) D and TGF-β were significantly decreased while IL-17 and IL-23 were significantly increased compared with the control group. VDR expression was significantly decreased in the RSA group compared with the control group. Logistic regression analysis showed a significant negative correlation between 25(OH) D in decidual tissues and RSA. These results indicated that vitamin D concentrations in the decidua are associated with inflammatory cytokine production, suggesting that vitamin D and VDR may play a role in the etiology of RSA.
Assuntos
Humanos , Feminino , Gravidez , Adulto , Adulto Jovem , Vitamina D/análogos & derivados , Aborto Habitual/metabolismo , Receptores de Calcitriol/análise , Decídua/química , 25-Hidroxivitamina D3 1-alfa-Hidroxilase/análise , Terceiro Trimestre da Gravidez , Vitamina D/análise , Vitamina D/metabolismo , Deficiência de Vitamina D/complicações , Modelos Logísticos , Fatores de Risco , Aborto Habitual/etiologia , Fator de Crescimento Transformador beta/análise , Receptores de Calcitriol/metabolismo , Estatísticas não Paramétricas , Interleucina-17/análise , Interleucina-23/análise , 25-Hidroxivitamina D3 1-alfa-Hidroxilase/metabolismoRESUMO
The effect of hydroxychloroquine (HCQ) on dry eye has not been fully determined. This study aimed to compare the 12-week efficacy of HCQ medication with that of a placebo in the management of dry eye in primary Sjögren's syndrome (pSS). A double-blind, randomized control study was conducted in 39 pSS subjects from May 2011 through August 2013. pSS was diagnosed based on the classification criteria of the American-European Consensus Group. Subjects received 300 mg of HCQ or placebo once daily for 12 weeks and were evaluated at baseline, 6, and 12 weeks, with a re-visit at 16 weeks after drug discontinuance. The fluorescein staining score, Schirmer test score, tear film break-up time (TBUT), and ocular surface disease index (OSDI) were measured, and tears and blood were collected for ESR, IL-6, IL-17, B-cell activating factor (BAFF), and Th17 cell analysis. Color testing was performed and the fundus was examined to monitor HCQ complications. Twenty-six subjects completed the follow-up. The fluorescein staining score and Schirmer test score did not differ significantly. The OSDI improved with medication in the HCQ group but was not significantly different between the groups. TBUT, serum IL-6, ESR, serum and tear BAFF, and the proportion of Th17 cells did not change in either group. HCQ at 300 mg daily for 12 weeks has no apparent clinical benefit for dry eye and systemic inflammation in pSS (ClinicalTrials.gov. NCT01601028).
Assuntos
Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fator Ativador de Células B/análise , Sedimentação Sanguínea , Método Duplo-Cego , Esquema de Medicação , Síndromes do Olho Seco/complicações , Ensaio de Imunoadsorção Enzimática , Hidroxicloroquina/uso terapêutico , Interleucina-16/análise , Interleucina-17/análise , Efeito Placebo , Estudos Prospectivos , Síndrome de Sjogren/complicações , Células Th17/citologia , Resultado do TratamentoRESUMO
Abstract Interleukin 17A (IL-17A) is a proinflammatory cytokine responsible for the initiation and propagation of inflammation. One of its actions is the recruitment of neutrophils to the site of infection. The aim of this study was to investigate whether there is association between IL-17A expression and neutrophil infiltration in periapical abscesses and periapical granulomas, as well as to find which type of T lymphocyte effector (CD4+ or CD8+) expresses IL-17A in these lesions. Elastase, CD4, CD8, and IL-17A were analyzed by immunohistochemistry and immunofluorescence, in the biopsies of periapical lesions. Abscess lesions exhibited the highest labeling area for IL-17A (p = 0.011). During double immunofluorescence staining, there were significantly more CD4+/IL-17A+ cells compared to CD8+/IL-17A+ cells, both in the abscesses (p = 0.025) and granulomas (p = 0.011). In conclusion, IL-17A was intensively expressed in periapical abscesses rich in neutrophils. The high percentage of IL-17A in these cases suggests the participation of this cytokine particularly in the acute stages of the inflammatory process of the periapical lesions.
Assuntos
Humanos , Abscesso Periapical/metabolismo , Granuloma Periapical/metabolismo , Granuloma Periapical/patologia , Interleucina-17/análise , Abscesso Periapical/patologia , Valores de Referência , Biópsia , Imuno-Histoquímica , Elastase Pancreática/análise , Linfócitos T CD4-Positivos/patologia , Linfócitos T CD4-Positivos/química , Antígenos CD4/análise , Imunofluorescência , Antígenos CD8/análise , Linfócitos T CD8-Positivos/patologia , Linfócitos T CD8-Positivos/química , Infiltração de NeutrófilosRESUMO
The sequestration of infected erythrocytes in the placenta can activate the syncytiotrophoblast to release cytokines that affect the micro-environment and influence the delivery of nutrients and oxygen to fetus. The high level of IL-10 has been reported in the intervillous space and could prevent the pathological effects. There is still no data of Th17 involvement in the pathogenesis of placental malaria. This study was conducted to reveal the influence of placental IL-17 and IL-10 levels on fetal weights in malaria placenta. Seventeen pregnant BALB/C mice were divided into control (8 pregnant mice) and treatment group (9 pregnant mice infected by Plasmodium berghei). Placental specimens stained with hematoxylin and eosin were examined to determine the level of cytoadherence by counting the infected erythrocytes in the intervillous space of placenta. Levels of IL-17 and IL-10 in the placenta were measured using ELISA. All fetuses were weighed by analytical balance. Statistical analysis using Structural Equation Modeling showed that cytoadherence caused an increased level of placental IL-17 and a decreased level of placental IL-10. Cytoadherence also caused low fetal weight. The increased level of placental IL-17 caused low fetal weight, and interestingly low fetal weight was caused by a decrease of placental IL-10. It can be concluded that low fetal weight in placental malaria is directly caused by sequestration of the parasites and indirectly by the local imbalance of IL-17 and IL-10 levels.
Assuntos
Animais , Feminino , Humanos , Masculino , Camundongos , Gravidez , Peso Fetal , Interleucina-10/análise , Interleucina-17/análise , Malária/metabolismo , Camundongos Endogâmicos BALB C , Placenta/química , Plasmodium berghei/fisiologia , Complicações Parasitárias na Gravidez/metabolismoRESUMO
Human amniotic membrane-derived mesenchymal stem cells (hAM-MSCs) are capable of differentiating into several lineages and possess immunomodulatory properties. In this study, we investigated the soluble factor-mediated immunomodulatory effects of hAM-MSCs. Mitogen-induced peripheral blood mononuclear cell (PBMC) proliferation was suppressed by hAM-MSCs in a dose-dependent manner as well as hAM-MSC culture supernatant. Moreover, interferon-gamma and interleukin (IL)-17 production significantly decreased from PBMC, whereas IL-10 from PBMCs and transforming growth factor beta (TGF-beta) production from hAM-MSCs significantly increased in co-cultures of hAM-MSCs and PBMCs. Production of several MSC factors, including hepatocyte growth factor (HGF), TGF-beta, prostaglandin E2 (PGE2), and indoleamine 2, 3 dioxygenase (IDO), increased significantly in hAM-MSCs co-cultured with PBMCs. These results indicate that the immunomodulatory effects of hAM-MSCs may be associated with soluble factors (TGF-beta, HGF, PGE2, and IDO), suggesting that hAM-MSCs may have potential clinical use in regenerative medicine.
Assuntos
Feminino , Humanos , Gravidez , Âmnio/citologia , Diferenciação Celular/imunologia , Técnicas de Cocultura , Dinoprostona/genética , Fator de Crescimento de Hepatócito/genética , Fatores Imunológicos/imunologia , Imunofenotipagem , Indolamina-Pirrol 2,3,-Dioxigenase/genética , Interferon gama/imunologia , Interleucina-10/análise , Interleucina-17/análise , Leucócitos Mononucleares/citologia , Células-Tronco Mesenquimais/citologia , RNA Mensageiro/química , Medicina Regenerativa/métodos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fator de Crescimento Transformador beta/genéticaRESUMO
The purpose of this study was to investigate clinical and immunological responses to Demodex on the ocular surface. Thirteen eyes in 10 patients with Demodex blepharitis and chronic ocular surface disorders were included in this study and treated by lid scrubbing with tea tree oil for the eradication of Demodex. We evaluated ocular surface manifestations and Demodex counts, and analyzed IL-1beta, IL-5, IL-7, IL-12, IL-13, IL-17, granulocyte colony-stimulating factor, and macrophage inflammatory protein-1beta in tear samples before and after the treatment. All patients exhibited ocular surface manifestations including corneal nodular opacity, peripheral corneal vascularization, refractory corneal erosion and infiltration, or chronic conjunctival inflammatory signs before treatment. After treatment, Demodex was nearly eradicated, tear concentrations of IL-1beta and IL-17 were significantly reduced and substantial clinical improvement was observed in all patients. In conclusion, we believe that Demodex plays an aggravating role in inflammatory ocular surface disorders.
Assuntos
Adolescente , Adulto , Idoso , Animais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Ácaros e Carrapatos/efeitos dos fármacos , Blefarite/tratamento farmacológico , Quimiocina CCL4/análise , Fator Estimulador de Colônias de Granulócitos/análise , Interleucina-12/análise , Interleucina-13/análise , Interleucina-17/análise , Interleucina-1beta/análise , Interleucina-5/análise , Interleucina-7/análise , Óleo de Melaleuca/uso terapêutico , Lágrimas/metabolismoRESUMO
Recently, the association of Th-17 cells or IL-17 with ocular inflammatory diseases such as uveitis, scleritis and dry eye syndrome was discovered. We assessed whether interleukin (IL)-17 was present in the tears of various ocular surface inflammatory diseases and the tear IL-17 concentrations were clinically correlated with various ocular surface inflammatory diseases. We measured concentrations of IL-17 in tears of normal subjects (n = 28) and patients (n = 141) with meibomian gland dysfunction (MGD), dry eye syndrome (DES), Sjogren syndrome (SS), Stevens-Johnson syndrome (SJS), graft-versus-host disease (GVHD), filamentary keratitis, and autoimmune keratitis associated with rheumatoid arthritis or systemic lupus erythematosus. Clinical epitheliopathy scores were based on the surface area of corneal and conjunctival fluorescein staining. The mean concentrations of IL-17 in tears of patients with filamentary keratitis, GVHD, autoimmune keratitis, SS, DES, MGD, SJS were significantly higher in order than that in normal subjects. Tear IL-17 concentration was significantly correlated with clinical epitheilopathy scores in the patients with systemic inflammatory disease, while tear IL-17 was not correlated with clinical severity of the cornea and conjunctiva in the dry eye patients without any systemic inflammatory disease. Tear IL-17 is likely to correlate clinically with corneal disease severity only in the patients with systemic inflammatory disease.
Assuntos
Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Síndromes do Olho Seco/metabolismo , Oftalmopatias/diagnóstico , Doenças Palpebrais/metabolismo , Doença Enxerto-Hospedeiro/metabolismo , Interleucina-17/análise , Ceratite/metabolismo , Glândulas Tarsais/fisiopatologia , Índice de Gravidade de Doença , Síndrome de Sjogren/metabolismo , Síndrome de Stevens-Johnson/metabolismo , Lágrimas/metabolismoRESUMO
Association of asthma with Type 2 T- helper system is well realized. Recent clinical evidence show that acute, severe exacerbations of asthma are associated with recruitment and activation of neutrophils in the airways. The lymphocytes T helper 17 [Th17] cells can probably recruit neutrophils to an inflammatory site through producing IL-17. The objective of this study was to investigate the level of interlukin-17 [IL-17] in serum and sputum of asthmatic subjects. Also, the study aimed at evaluating the correlation between concentrations of IL-17 and the frequency of inflammatory cells in the sputum of asthma at different stages. Fifty newly diagnosed asthmatics and 12 non-asthmatics healthy subjects, as the control group, entered this prospective study. None of them reported any recent history of infection and steroid usage. Then, samples from venous blood and sputum [Induced by Hypertonic saline%5] were obtained. The severity of asthma was classified according to GINA 2004 guidelines. The Concentrations of IL-17 in serum and supernatant of induced sputum were determined by ELISA method. Total serum IgE level was also determined in order to classify asthmatic subjects into allergic and non-allergic groups. As the findings of the study suggest, serum IL-17 level was significantly higher in asthmatic patients than in the normal control subjects [78.8 +/- 58.7 vs 17.7 +/- 2.4 pg/dl, P=0.025]. IL-17 was found to be significantly increased in sputum of the subjects with asthma, as compared to the control subjects [31.6=/-20.9 vs 21.5 +/- 16.6 pg/dl, P=0.012]. In addition, allergic and non-allergic asthmatic patients showed a significantly higher concentration level of serum IL-17 than the normal controls [80.8 +/- 50.3, P+0.023 and 102.7 +/- 43.6, P=0.002vs 17.7 +/- 2.4 ng/ml]. But, it was found that the levels of both serum and sputum IL-17 in the allergic asthma group were not significantly higher than those in the non-allergic asthmatics. Moreover, serum IgE level was significantly higher in allergic asthmatic patients than non-allergic asthmatic and normal control subjects [295.8=/-168 vs. 99.1 +/- 90.0 P=0.001 and 49.7 +/- 41.8, P=0.001]. The results further revealed that macrophage was decreased in sputum but neutrophil and eosinophil were significantly increased. However, the increase of IL-17 was not correlated with asthma severity. Besides, there was no significant difference between allergic and non-allergic asthmatic subjects, in terms of IL-17. We propose that IL-17 may play a role in the airway inflammation of asthmatics by recruiting neutrophils into the lung, no matter if they are suffering from allergic or non-allergic asthma